Hematology NewsSEER analysis reveals medication adherence factors in newly diagnosed myelomaOctober 24, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsPembrolizumab shows promise for relapsed/refractory PMBCLOctober 24, 2019B Cell LymphomaLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology NewsASCO to award $50,000 young investigator grant to study MCLOctober 23, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsVitamin D deficiency appears to worsen survival in Hodgkin lymphomaOctober 17, 2019Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsIbrutinib linked to hypertension in B-cell malignanciesOctober 15, 2019B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsBest treatment approach for early stage follicular lymphoma is unclearOctober 9, 2019Follicular LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsFollow-up shows favorable results with acalabrutinib in MCLOctober 8, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsWhat is the optimal duration of maintenance in myeloma?October 8, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsTargeted agents vs. chemoimmunotherapy as first-line treatment of CLLOctober 3, 2019CLLLymphoma & Plasma Cell DisordersB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsDecoding biosimilar approvalsOctober 1, 2019B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsStudy finds no standard for treatment discontinuation in myelomaOctober 1, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsSecond-generation anti-BCMA CAR T-cell therapy shows promise in myeloma trialSeptember 27, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsGerman CLLM1 study: 4-year data raise concerns about lenalidomide maintenanceSeptember 27, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsICLL-07 trial: MRD-driven strategy yields prolonged survivalSeptember 27, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsDaratumumab approved in combo with VTd for transplant-eligible multiple myelomaSeptember 26, 2019Multiple MyelomaTransplantLymphoma & Plasma Cell Disorders
